PCN94 Comparative Analysis of Cost-Effectiveness Bevacizumab + Paclitaxel Versus Using Only Versus Paclitaxel as First Line Treatment of Patients with Metastatic Breast Cancer in the IMSS (Mexican Institute of Social Security)